About Us

Establishing the global standard in cannabinoid products and therapies by unlocking the full therapeutic potential of cannabinoids, through pharmaceutical-grade quality, proprietary science, and deep regulatory expertise, addressing serious medical conditions and improving patients’ lives worldwide.

Backed by Science.

API used in 30+ third-party clinical trials
Global regulatory excellence
Cutting-edge formulations Evidence-driven innovation

Built for Scale.

Established Active Pharmaceutical Ingredient (API) leadership
Expanding clinical pipeline Nutraceutical and animal health expansion
Broad regulatory and licensing infrastructure

Focused on Patients

Targeting improved patient outcomes
Working toward better quality of life
Bridging critical gaps
Holistic impact

With pharmaceutical-grade cannabinoid quality, global regulatory expertise and supply relationships with leading multinationals, Brains Bio is advancing cannabinoid science worldwide

Senior Leadership Team

Our executive team combines decades of experience from GSK, Pfizer, Biogen, Vertex, and Novartis with specialized cannabinoid expertise, creating unmatched capability to navigate complex regulatory pathways and deliver breakthrough therapeutic solutions.

Rick Brar

CEO and Chairman

Terry O'Regan

President

Jas Kalsi

Chief Financial Officer

Dean Billington

COO

William Purves

Chief Commercial Officer

Strategic & Supply Relationships with Leading Multinationals

Brains is a global leader in integrated cannabinoid development, with an EU-GMP cannabinoid platform supplying APIs and building Rx, nutraceutical, and animal health businesses – revenue generating, with established supply relationships

Jas Kalsi

An experienced Chartered Professional Accountant with over 30 years of experience in providing personal and corporate taxation, corporate restructuring, financing, public offering and human resources management services. Kalsi is the Chief Financial Officer for Brains Bioceutical Corp., a global manufacturer of naturally-sourced active pharmaceutical ingredients (APIs). In this role, Kalsi is responsible for overseeing and managing the fiscal health of the group, implementing best practices with respect to finance, accounting and internal controls, obtaining funding, providing recommendations on mergers and acquisitions and working collaboratively with the CEO and Board of Directors on strategy. In addition, Kalsi will be responsible to regulatory entities and authorities, including any security exchange commissions.

Kalsi was an audit partner at KPMG focusing on small, medium and large private, government sector and public audit clients. He was the Human Resource Manager in charge of recruiting, staff development and training, and a member of KPMG’s Professional Practice Group. Subsequent to KPMG, Kalsi was the Chief Financial Officer / Chief Executive Officer of a variety of private companies including 6.5 years with a pharmaceutical fulfillment provider and API developer.

Kalsi has a proven track record in hiring top-level senior executives, restructuring companies to minimize tax and maximize cash flows, raising financing and creating a cohesive culture.

Kalsi has a passion for wellness and has created several initiatives and partnered with several leading-edge individuals to help people create and enjoy the best versions of themselves. He sees the use cannabinoids as a major tool to facilitate one’s optimum lifestyle.

With the team and infrastructure in place, Brains Bioceutical has quickly become an industry leader in both the nutraceutical and pharmaceutical cannabinoid industries, with several clinical trials and academic studies underway evaluating the efficacy of cannabinoids to treat major diseases. Under Kalsi’s leadership, Brains Bioceutical has already established market dominance, as it is the only company in the world to sell bulk API commercially around the world, supporting both the pharmaceutical and wellness sectors. With ambitious plans to expand Brains Bioceutical into a global biotech company specializing in cannabinoid health and wellness solutions, Kalsi is pioneering a new frontier in medicinal and wellness solutions across the world.

About Us

Backed by Science.

Built for Scale.

Focused on Patients

Senior Leadership Team

Rick Brar

CEO and Chairman

Terry O'Regan

President

Jas Kalsi

Chief Financial Officer

Dean Billington

COO

William Purves

Chief Commercial Officer

Strategic & Supply Relationships with Leading Multinationals

Contact Us

General Inquiries:

About Us

Backed by Science.

Built for Scale.

Focused on Patients

Senior Leadership Team

Rick Brar

CEO and Chairman

Terry O'Regan

President

Jas Kalsi

Chief Financial Officer

Dean Billington

COO

William Purves

Chief Commercial Officer

Strategic & Supply Relationships with Leading Multinationals

Contact Us

General Inquiries:

Jas Kalsi

Chief Financial Officer

Jennifer Archibald

Chief Financial Officer

Barinder Bhullar

Senior Vice President, Corporate Affairs

William Purves

Chief Commercial Officer

Gurdeep Bains

VP of Business Development

Jorja’s Story

A father’s journey to saving his daughter’s life

Dr. Mike Bowen

Dr. Jack Taunton

Dr. Sharon Gurm

Dr. David Putrino

Dr. Gerry Ramogida

Norma Sebestyen

Dean Billington

COO

Terry O’Regan

President

Rick Brar

CEO and Chairman